These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9294415)

  • 21. The use of a neurotoxic lectin, volkensin, to induce loss of identified motoneuron pools.
    Nógrádi A; Vrbová G
    Neuroscience; 1992 Oct; 50(4):975-86. PubMed ID: 1448208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons.
    Pollack AE; Harrison MB; Wooten GF; Fink JS
    Brain Res; 1993 Dec; 631(1):161-6. PubMed ID: 8298989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anatomical and neurochemical evidence for suicide transport of a toxic lectin, volkensin, injected in the rat dorsal hippocampus.
    Contestabile A; Fasolo A; Virgili M; Migani P; Villani L; Stirpe F
    Brain Res; 1990 Dec; 537(1-2):279-86. PubMed ID: 1707729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Location of nicotinic and muscarinic cholinergic and mu-opiate receptors in rat cerebral neocortex: evidence from thalamic and cortical lesions.
    Sahin M; Bowen WD; Donoghue JP
    Brain Res; 1992 May; 579(1):135-47. PubMed ID: 1320443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Volkensin from Adenia volkensii Harms (kilyambiti plant), a type 2 ribosome-inactivating protein.
    Chambery A; Di Maro A; Monti MM; Stirpe F; Parente A
    Eur J Biochem; 2004 Jan; 271(1):108-17. PubMed ID: 14686924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related changes in the density of muscarinic cholinergic M1 and M2 receptor subtypes in pyramidal neurons of the rat hippocampus.
    Amenta F; Liu A; Giannella M; Pigini M; Tayebati SK; Zaccheo D
    Eur J Histochem; 1995; 39(2):107-16. PubMed ID: 7549013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The time course of changes in D1 and D2 receptor binding in the striatum following a selective lesion of striatonigral neurons.
    Harrison MB; Wiley RG; Wooten GF
    Brain Res; 1992 Nov; 596(1-2):330-6. PubMed ID: 1334779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nucleus basalis lesion on muscarinic receptor subtypes.
    Bogdanovic N; Islam A; Nilsson L; Bergström L; Winblad B; Adem A
    Exp Brain Res; 1993; 97(2):225-32. PubMed ID: 8150042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeccin and volkensin but not abrin are effective suicide transport agents in rat CNS.
    Wiley RG; Stirpe F
    Brain Res; 1988 Jan; 438(1-2):145-54. PubMed ID: 2449931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of the muscarine receptor antagonist heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at cholinoceptor sites.
    Christopoulos A; Loiacono R; Mitchelson F
    Eur J Pharmacol; 1993 Jun; 246(1):1-8. PubMed ID: 8354340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons.
    Tallaksen-Greene SJ; Wiley RG; Albin RL
    Brain Res; 1992 Oct; 594(1):165-70. PubMed ID: 1334764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glial reaction to volkensin-induced selective degeneration of central neurons.
    Cevolani D; Bentivoglio M; Strocchi P
    Brain Res Bull; 2001 Mar; 54(4):353-61. PubMed ID: 11306186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W; Gillberg PG; Nordberg A
    Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosteric effects of the alkane-bis-ammonium compound W84 and of tacrine on [3H]pirenzepine binding at M1-receptors in rat cerebral cortex.
    Mohr K; Tränkle C
    Pharmacol Toxicol; 1994 Dec; 75(6):391-4. PubMed ID: 7899262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approaches to imaging based on effects of neurotoxins.
    Francis PT; Chessell IP; Bowen DM
    Dement Geriatr Cogn Disord; 1997; 8(2):117-22. PubMed ID: 9065325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury.
    Verbois SL; Scheff SW; Pauly JR
    J Neurotrauma; 2002 Dec; 19(12):1569-85. PubMed ID: 12542858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of hippocampal norepinephrine release by cholinergic agonists is altered by AF64A lesion.
    Potter PE; Thorne B; Gaughan C
    Brain Res Bull; 1997; 42(2):153-60. PubMed ID: 8971421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist.
    Dijk SN; Francis PT; Stratmann GC; Bowen DM
    Br J Pharmacol; 1995 Aug; 115(7):1169-74. PubMed ID: 7582540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aging and cholinergic deafferentation on putative muscarinic cholinergic receptor subtypes in rat cerebral cortex.
    Norman AB; Blaker SN; Thal L; Creese I
    Neurosci Lett; 1986 Oct; 70(2):289-94. PubMed ID: 3774231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.